Swiss drug giant Novartis has signed a long-term lease on property at 181 Massachusetts Ave., in Cambridge, MA, according to a report today in the Boston Globe. MIT reportedly owns the land, where it has a two-acre parking lot. Novartis, which already has the global headquarters of its R&D unit, Novartis Institutes for BioMedical Research, in Cambridge, has no immediate plans to develop the land it has leased, company spokesman Jeffrey Lockwood says.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
